Year: 2018
Type: article
Abstract: CRISPR advances genome engineering by directing endonuclease sequence specificity with a guide RNA molecule (gRNA). For precisely targeting a gene for modification, each genetic construct requires a unique gRNA. By generating a gRNA against the flippase recognition target (FRT) site, a common genetic element shared by multiple genetic collections, CRISPR-FRT circumvents this design constraint to provide a broad platform for fast, scarless, off-the-shelf genome engineering.
Source: Nature Communications
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $6,990
Awards: G1041412011, G129467647, G2147181636, G2224659361, G306787497, In vivo multidrug-tolerant persister cells and their evolution in the face of antibiotic treatment: genetic and physiological adaptation mechanisms, Elucidating the role of two novel toxin-antitoxin modules in Escherichia coli multidrug tolerance., Functional Determinants in G-Protein-Coupled Receptors, G4603166441, G4797008958, ABI Innovation: Towards Recovery of Biological Information, G763275908, In-depth analysis of Pseudomonas aeruginosa persistence mechanisms, G9000007726, G9000114762, G9000217251, G9000241198, G9000267799, G9000318801
OpenAlex ID: W2805453650
